Pharma in Silica
PrivateLast Round
Seed
May 25, 2026
Total Funding Raised
$4.42M
Company Overview
Pharma in Silica is a pharmaceutical company that develops proprietary silica nanocarrier technology to create precise, well-tolerated chemotherapy treatments for solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharma in Silica Comparables
Compare Pharma in Silica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Westwood Bioscience | 83% | |
| NanOlogy, LLC | 79% | |
| DelSiTech | 73% |
Pharma in Silica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 25, 2026 | ||||
| Seed | Oct 30, 2024 | ||||
| Seed | May 2, 2023 |
Pharma in Silica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Seed |
| Keiretsu Forum Canada | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 30% MoM.
- Mar 15, 2025
Monthly visitors increased 36% MoM.
Pharma in Silica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pharma in Silica's valuation, stock price, and market status.
Is Pharma in Silica a public or private company?
Pharma in Silica is a private company.
What is the current stock price of Pharma in Silica?
Pharma in Silica is a private company, so its shares have no public market price. Caplight tracks Pharma in Silica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pharma in Silica worth (valuation)?
Valuation information for Pharma in Silica is not publicly available.
Can I buy Pharma in Silica stock?
Pharma in Silica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pharma in Silica's last funding round?
Pharma in Silica's most recent funding round was Seed on May 25, 2026.
Who are the main investors in Pharma in Silica?
Key investors in Pharma in Silica include Investissement Québec, Keiretsu Forum Canada.
Will Pharma in Silica IPO soon?
No public IPO plans have been announced for Pharma in Silica.
How can I track Pharma in Silica secondary market activity?
Caplight tracks bids, offers, and trades in Pharma in Silica's shares on secondary markets.